TYRA 300; dabogratinibum; dabogratinib
For scientific research only, not for patients.
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
Chemical Name:
(R)-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-3-(6-(6-(methylsulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-3-yl)-1H-indazole
SMILES Code:
O=S(N(C1)CC1(C2)CN2C(N=C3)=CC=C3C4=NNC5=CC=C(O[C@H](C)C6=C(Cl)C=NC=C6Cl)C=C54)(C)=O
InChi Code:
InChI=1S/C25H24Cl2N6O3S/c1-15(23-19(26)9-28-10-20(23)27)36-17-4-5-21-18(7-17)24(31-30-21)16-3-6-22(29-8-16)32-11-25(12-32)13-33(14-25)37(2,34)35/h3-10,15H,11-14H2,1-2H3,(H,30,31)/t15-/m1/s1
InChi Key:
JOAFWIHZEBKYQK-OAHLLOKOSA-N
Keyword:
2800223-30-5;CAS:2800223-30-5;CAS:2800223-30-5;TYRA-300;TYRA300;TYRA 300;dabogratinibum;dabogratinib
Solubility:
Storage:
Description:
TYRA-300 is an orally effective FGFR3 selective inhibitor.
Target: FGFR3


![5,7-dichloro-2,3-dimethylpyrido[3,4-b]pyrazine](https://www.caerulumpharm.com/uploads/CAS2563588-61-2结构图.png)



